- Home
- STRO vs SFWL Comparison
STRO vs SFWL Comparison
Compare STRO & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SFWL
- Stock Information
- Founded
- STRO 2003
- SFWL 2001
- Country
- STRO United States
- SFWL China
- Employees
- STRO N/A
- SFWL N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SFWL Trucking Freight/Courier Services
- Sector
- STRO Health Care
- SFWL Industrials
- Exchange
- STRO Nasdaq
- SFWL Nasdaq
- Market Cap
- STRO 77.7M
- SFWL 74.2M
- IPO Year
- STRO 2018
- SFWL 2023
- Fundamental
- Price
- STRO $0.90
- SFWL $1.01
- Analyst Decision
- STRO Hold
- SFWL
- Analyst Count
- STRO 7
- SFWL 0
- Target Price
- STRO $5.47
- SFWL N/A
- AVG Volume (30 Days)
- STRO 1.2M
- SFWL 10.3K
- Earning Date
- STRO 05-08-2025
- SFWL 06-10-2025
- Dividend Yield
- STRO N/A
- SFWL N/A
- EPS Growth
- STRO N/A
- SFWL 4.79
- EPS
- STRO N/A
- SFWL 0.13
- Revenue
- STRO $66,434,000.00
- SFWL $504,158,000.00
- Revenue This Year
- STRO N/A
- SFWL N/A
- Revenue Next Year
- STRO N/A
- SFWL N/A
- P/E Ratio
- STRO N/A
- SFWL $7.72
- Revenue Growth
- STRO N/A
- SFWL 24.75
- 52 Week Low
- STRO $0.52
- SFWL $0.81
- 52 Week High
- STRO $5.17
- SFWL $2.15
- Technical
- Relative Strength Index (RSI)
- STRO 50.82
- SFWL 52.77
- Support Level
- STRO $0.86
- SFWL $0.94
- Resistance Level
- STRO $0.99
- SFWL $1.02
- Average True Range (ATR)
- STRO 0.09
- SFWL 0.05
- MACD
- STRO 0.00
- SFWL -0.00
- Stochastic Oscillator
- STRO 68.44
- SFWL 62.50
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.